Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to pay

1:11 PM ET Mon, 7 Jan 2019

Jim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.